Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc. financial statements

Carisma Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 19.63MEODHD
Net income−USD 60.48MEODHD
Cash and equivalentsUSD 17.91MEODHD
Total debtUSD 2.48MEODHD

Carisma Therapeutics, Inc. financials on 6ix · Carisma Therapeutics, Inc. on 6ix